Back to YC Companies
Macromoltek
Winter 2018
Active
Computational antibody design
14 people View on YC
Macromoltek at a glance
- Y Combinator batch
- Winter 2018
- Status
- Active
- Industry
- Healthcare
- Team size
- 14 people
- Location
- Not recorded
- Website
- Not recorded
Every field above comes from the Y Combinator company record. Nothing is estimated.
About Macromoltek
Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.
Tags:
AI-powered Drug Discovery
Deep Learning
Therapeutics